Cargando…

U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731891/ https://www.ncbi.nlm.nih.gov/pubmed/23900225 http://dx.doi.org/10.1038/mtna.2013.44

Ejemplares similares

U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo
por: Goraczniak, Rafal, et al.
Publicado: (2013)

circ-Grm1 promotes pulmonary artery smooth muscle cell proliferation and migration via suppression of GRM1 expression by FUS
por: Sun, Shijing, et al.
Publicado: (2021)

Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model
por: de Jel, Miriam Martha, et al.
Publicado: (2019)

Cellular and cytokine-dependent immunosuppressive mechanisms of grm1-transgenic murine melanoma
por: Alb, Miriam, et al.
Publicado: (2012)

MicroRNA-497 inhibits multiple myeloma growth and increases susceptibility to bortezomib by targeting Bcl-2
por: Tian, Faqing, et al.
Publicado: (2019)

Deleterious GRM1 Mutations in Schizophrenia
por: Ayoub, Mohammed Akli, et al.
Publicado: (2012)

BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1
por: Tu, Kangsheng, et al.
Publicado: (2022)

Ouabain suppresses the growth and migration abilities of glioma U-87MG cells through inhibiting the Akt/mTOR signaling pathway and downregulating the expression of HIF-1α
por: Yang, Xiao-Sa, et al.
Publicado: (2021)

Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1
por: Mena, Salvador, et al.
Publicado: (2012)

Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
Publicado: (2021)

Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo
por: Chen, Ho-Chung, et al.
Publicado: (2017)

miR-140-3p Suppresses Cell Growth and Induces Apoptosis in Colorectal Cancer by Targeting PD-L1 [Corrigendum]
Publicado: (2020)

Securidaca–saponins are natural inhibitors of AKT, MCL-1, and BCL2L1 in cervical cancer cells [Corrigendum]
Publicado: (2019)

SMC1A promotes growth and migration of prostate cancer in vitro and in vivo
por: Pan, Xiu-Wu, et al.
Publicado: (2021)

Targeting Bcl-2/Bcl-X(L) Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts
por: Némati, Fariba, et al.
Publicado: (2014)

Corrigendum to “Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo”
por: Ho, Mao-Lin, et al.
Publicado: (2015)

Ex vivo distribution of gold nanoparticles in choroidal melanoma [Corrigendum]
Publicado: (2018)

Corrigendum to “Presymptomatic Treatment with Acetylcholinesterase Antisense Oligonucleotides Prolongs Survival in ALS (G93A-SOD1) Mice”
por: Gotkine, Marc, et al.
Publicado: (2015)

Gene silencing of NOB1 by lentivirus suppresses growth and migration of human osteosarcoma cells
por: Chen, Bingpeng, et al.
Publicado: (2022)

In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts [Corrigendum]
Publicado: (2019)

The role of group II metabotropic glutamate receptors in cognition and anxiety: Comparative studies in GRM2(−/−), GRM3(−/−) and GRM2/3(−/−) knockout mice
por: De Filippis, Bianca, et al.
Publicado: (2015)

TGF-β induces growth suppression in multiple myeloma MM.1S cells via E2F1
por: Liu, Xialei, et al.
Publicado: (2021)

Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice
por: Lyon, Louisa, et al.
Publicado: (2008)

Metformin suppresses hypoxia-induced migration via the HIF-1α/VEGF pathway in gallbladder cancer in vitro and in vivo
por: Ye, Jianwen, et al.
Publicado: (2019)

Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness
por: Isola, Allison L., et al.
Publicado: (2017)

Diels-Alder cycloadditions in water for the straightforward preparation of peptide–oligonucleotide conjugates
por: Marcha´n, Vicente, et al.
Publicado: (2006)

Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo [Corrigendum]
Publicado: (2020)

Metabotropic Glutamate Receptor 1 (Grm1) Is An Oncogene In Epithelial Cells
por: Martino, Jeffrey J, et al.
Publicado: (2012)

PPT1 inhibition enhances the antitumor activity of anti–PD-1 antibody in melanoma
por: Sharma, Gaurav, et al.
Publicado: (2022)

Loss in MCL-1 function sensitizes non-Hodgkin's lymphoma cell lines to the BCL-2-selective inhibitor venetoclax (ABT-199)
por: Phillips, D C, et al.
Publicado: (2016)

Corrigendum to “Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma”
por: Macià, A., et al.
Publicado: (2016)

Crim1 suppresses left ventricular hypertrophy
por: Yang, Long, et al.
Publicado: (2019)

CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway [Corrigendum]
por: Feng, Z, et al.
Publicado: (2019)

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
por: Watson, Lauren M., et al.
Publicado: (2017)

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
por: Watson, Lauren M., et al.
Publicado: (2017)

Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44
por: Watson, Lauren M., et al.
Publicado: (2017)

MicroRNA-26b suppresses autophagy in breast cancer cells by targeting DRAM1 mRNA, and is downregulated by irradiation
por: Meng, Cuida, et al.
Publicado: (2021)

Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway [Corrigendum]
Publicado: (2021)

Corrigendum to “A Simple Method to Assess In Vivo Proliferation in Lung Vasculature with EdU: The Case of MMC-Induced PVOD in Rat”
por: Antigny, Fabrice, et al.
Publicado: (2017)

Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations
por: Hu, S, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6cl5464v6fdqsqkh8i56dnsapg